Common asthma drug shows promise for reversing fatty liver
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jun-2026 10:15 ET (19-Jun-2026 14:15 GMT/UTC)
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options remain limited. A new paper published in Nature partner journal (npj) Metabolic Health and Disease suggests that a widely used asthma medication, formoterol, could potentially offer a different therapeutic pathway altogether.
A largely overlooked structure inside our cells may play a crucial role in how the brain forms, offering new insight into developmental disorders and potential therapies.
A new study explored whether women visualised a vaccine would have a positive or negative impact on their babies, and if that affected their decision to be vaccinated. The findings, published in the journal Social Science & Medicine, showed that mental images were common and – depending on whether that mental image was a positive or negative one, and about the impacts of diseases or the vaccine itself – could be used in some cases to predict if and when the women ultimately became vaccinated during pregnancy.
Man-made 'forever chemicals' have been detected in 98.8% of blood tests, in a new study which examined more than 10,500 samples.Man-made 'forever chemicals' have been detected in 98.8% of blood tests, in a new study which examined more than 10,500 samples.
Over the past decade, organoid research has boomed and revolutionized biomedicine, with wide industrial applications and regulatory recognition. However, comprehensive reviews on organoid-related regulations and IND-approved drugs remain insufficient. This article reviews relevant advances in regulations and IND applications, and discusses the prospects and limitations of organoid models.